EX-99.1 2 exhibit991-segmentrecastld.htm EX-99.1 Document

AGILENT TECHNOLOGIES, INC.
LIFE SCIENCES AND DIAGNOSTICS MARKETS SEGMENT
(Unaudited)
(In millions, except margins data)FY24
Q1Q2Q3Q4Total
Revenue$620 $604 $585 $657 $2,466 
Gross margin %54.9 %55.1 %54.4 %53.8 %54.5 %
Research and development expenses$66 $64 $59 $61 $250 
Selling, general and administrative expenses$160 $154 $145 $152 $611 
Income from operations$114 $115 $114 $141 $484 
Operating margin %18.4 %19.0 %19.6 %21.5 %19.6 %
FY23
Q1Q2Q3Q4Total
Revenue$719 $726 $661 $674 $2,780 
Gross margin %57.2 %57.0 %56.5 %55.8 %56.7 %
Research and development expenses$71 $72 $61 $65 $269 
Selling, general and administrative expenses$169 $166 $147 $151 $633 
Income from operations$171 $176 $166 $160 $673 
Operating margin %23.8 %24.2 %25.1 %23.7 %24.2 %
FY22
Q1Q2Q3Q4Total
Revenue$670 $690 $718 $766 $2,844 
Gross margin %57.3 %57.2 %57.5 %56.0 %57.0 %
Research and development expenses$66 $66 $66 $68 $266 
Selling, general and administrative expenses$161 $157 $162 $163 $643 
Income from operations$157 $171 $185 $198 $711 
Operating margin %23.4 %24.8 %25.8 %25.8 %25.0 %

Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, business exit and divestiture costs and change in fair value of contingent consideration.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.








1


AGILENT TECHNOLOGIES, INC.
AGILENT CROSSLAB SEGMENT
(Unaudited)
(In millions, except margins data)FY24
Q1Q2Q3Q4Total
Revenue$686 $664 $691 $706 $2,747 
Gross margin %56.9 %56.6 %57.7 %56.3 %56.9 %
Research and development expenses$29 $26 $25 $25 $105 
Selling, general and administrative expenses$139 $134 $126 $133 $532 
Income from operations$222 $216 $248 $239 $925 
Operating margin %32.4 %32.5 %35.9 %33.8 %33.7 %
FY23
Q1Q2Q3Q4Total
Revenue$652 $660 $672 $672 $2,656 
Gross margin %55.1 %53.7 %56.4 %55.8 %55.3 %
Research and development expenses$26 $27 $24 $26 $103 
Selling, general and administrative expenses$138 $136 $123 $129 $526 
Income from operations$195 $192 $232 $220 $839 
Operating margin %30.0 %29.0 %34.5 %32.8 %31.6 %
FY22
Q1Q2Q3Q4Total
Revenue$648 $613 $639 $663 $2,563 
Gross margin %55.3 %54.8 %55.5 %56.2 %55.4 %
Research and development expenses$24 $23 $23 $24 $94 
Selling, general and administrative expenses$139 $135 $137 $137 $548 
Income from operations$195 $178 $194 $212 $779 
Operating margin %30.1 %29.0 %30.4 %31.9 %30.4 %

Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, business exit and divestiture costs and change in fair value of contingent consideration.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.








2


AGILENT TECHNOLOGIES, INC.
APPLIED MARKETS SEGMENT
(Unaudited)
(In millions, except margins data)FY24
Q1Q2Q3Q4Total
Revenue$352 $305 $302 $338 $1,297 
Gross margin %56.4 %54.2 %55.2 %55.0 %55.2 %
Research and development expenses$25 $23 $23 $23 $94 
Selling, general and administrative expenses$82 $78 $74 $77 $311 
Income from operations$92 $64 $70 $86 $312 
Operating margin %26.1 %21.0 %23.2 %25.3 %24.0 %
FY23
Q1Q2Q3Q4Total
Revenue$385 $331 $339 $342 $1,397 
Gross margin %57.6 %54.9 %55.5 %55.7 %56.0 %
Research and development expenses$26 $26 $23 $25 $100 
Selling, general and administrative expenses$86 $83 $73 $77 $319 
Income from operations$110 $72 $92 $89 $363 
Operating margin %28.5 %21.9 %27.2 %25.9 %26.0 %
FY22
Q1Q2Q3Q4Total
Revenue$356 $304 $361 $420 $1,441 
Gross margin %55.6 %54.2 %55.9 %56.8 %55.7 %
Research and development expenses$26 $25 $26 $26 $103 
Selling, general and administrative expenses$83 $83 $83 $84 $333 
Income from operations$89 $57 $93 $128 $367 
Operating margin %24.9 %18.8 %25.7 %30.5 %25.5 %

Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, business exit and divestiture costs and change in fair value of contingent consideration.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.








3